Treasurer of the State of North Carolina Grows Stock Position in The Cooper Companies, Inc. (NASDAQ:COO)

Treasurer of the State of North Carolina increased its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 0.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 88,167 shares of the medical device company’s stock after purchasing an additional 400 shares during the quarter. Treasurer of the State of North Carolina’s holdings in Cooper Companies were worth $8,105,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of the stock. JPMorgan Chase & Co. raised its holdings in shares of Cooper Companies by 1.5% in the 4th quarter. JPMorgan Chase & Co. now owns 5,004,523 shares of the medical device company’s stock valued at $460,066,000 after purchasing an additional 74,501 shares in the last quarter. Geode Capital Management LLC increased its holdings in Cooper Companies by 2.3% in the fourth quarter. Geode Capital Management LLC now owns 4,906,463 shares of the medical device company’s stock valued at $449,907,000 after buying an additional 109,907 shares during the last quarter. Victory Capital Management Inc. raised its stake in Cooper Companies by 14.6% in the fourth quarter. Victory Capital Management Inc. now owns 4,525,018 shares of the medical device company’s stock valued at $415,985,000 after buying an additional 574,899 shares in the last quarter. Norges Bank purchased a new stake in Cooper Companies during the 4th quarter worth about $217,906,000. Finally, FMR LLC boosted its position in shares of Cooper Companies by 97.6% during the 4th quarter. FMR LLC now owns 2,218,112 shares of the medical device company’s stock worth $203,911,000 after acquiring an additional 1,095,805 shares in the last quarter. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Cooper Companies Trading Up 2.8 %

NASDAQ COO opened at $77.46 on Monday. The firm’s fifty day moving average is $84.64 and its two-hundred day moving average is $94.52. The Cooper Companies, Inc. has a one year low of $69.81 and a one year high of $112.38. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The firm has a market cap of $15.49 billion, a PE ratio of 39.72, a P/E/G ratio of 2.25 and a beta of 1.01.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.92. The firm had revenue of $964.70 million for the quarter, compared to analyst estimates of $981.25 million. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. Analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Analyst Ratings Changes

Several brokerages have recently weighed in on COO. Stifel Nicolaus cut their target price on Cooper Companies from $115.00 to $105.00 and set a “buy” rating on the stock in a research report on Friday, March 7th. Robert W. Baird cut their price objective on shares of Cooper Companies from $117.00 to $107.00 and set an “outperform” rating on the stock in a report on Friday, March 7th. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a report on Friday, March 7th. Citigroup dropped their target price on shares of Cooper Companies from $115.00 to $110.00 and set a “buy” rating on the stock in a research report on Friday, March 7th. Finally, BNP Paribas raised shares of Cooper Companies to a “hold” rating in a research report on Thursday, March 13th. Four investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $110.25.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.